A Randomized Investigator Blinded Multi-Center Clinical Study To Compare Patient Outcomes and Clinical Effectiveness of Telithromycin Versus Azithromycin in Outpatients With Lower Respiratory Tract Infections.

Trial Profile

A Randomized Investigator Blinded Multi-Center Clinical Study To Compare Patient Outcomes and Clinical Effectiveness of Telithromycin Versus Azithromycin in Outpatients With Lower Respiratory Tract Infections.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2009

At a glance

  • Drugs Azithromycin; Telithromycin
  • Indications Acute exacerbations of chronic bronchitis; Bacterial infections; Community-acquired pneumonia; Respiratory tract infections
  • Focus Therapeutic Use
  • Acronyms KEYS
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Sep 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 25 Aug 2009 Actual number of patients changed from 4100 to 2051 as reported by ClinicalTrials.gov.
    • 22 Apr 2008 Status changed from in progress to completed, according to clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top